Holdings of Select Health Care Portfolio
Fidelity Select Portfolios · Original filing · Compare with another fund · Report an error
- Net assets
- 6.2B $ including 6B $ in equities, 97.3 %
- Positions
- 100 in 11 countries
- Top ten
- 42.1 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 408,000 | 429.2M $ | 6.93 % |
| 2 | Danaher Corp | 1,880,000 | 396M $ | 6.39 % |
| 3 | Boston Scientific Corp | 4,850,000 | 372.7M $ | 6.01 % |
| 4 | Johnson & Johnson | 1,400,000 | 347.8M $ | 5.61 % |
| 5 | AbbVie Inc | 1,140,000 | 264.6M $ | 4.27 % |
| 6 | Ascendis Pharma A/S | 716,000 | 167.2M $ | 2.70 % |
| 7 | UCB SA | 540,000 | 161M $ | 2.60 % |
| 8 | Gilead Sciences Inc | 1,080,000 | 160.9M $ | 2.60 % |
| 9 | Merck & Co Inc | 1,280,000 | 158.5M $ | 2.56 % |
| 10 | Argenx SE | 200,000 | 153.4M $ | 2.48 % |
| 11 | Edwards Lifesciences Corp | 1,600,000 | 138.4M $ | 2.23 % |
| 12 | CVS Health Corp | 1,500,000 | 119.9M $ | 1.93 % |
| 13 | Alnylam Pharmaceuticals Inc | 340,000 | 113.2M $ | 1.83 % |
| 14 | Thermo Fisher Scientific Inc | 212,000 | 110.5M $ | 1.78 % |
| 15 | Cogent Biosciences Inc | 2,560,000 | 99.5M $ | 1.60 % |
| 16 | McKesson Corp | 95,000 | 93.8M $ | 1.51 % |
| 17 | BrightSpring Health Services Inc | 2,080,000 | 86.2M $ | 1.39 % |
| 18 | Moderna Inc | 1,600,000 | 85.7M $ | 1.38 % |
| 19 | Insmed Inc | 560,000 | 83.6M $ | 1.35 % |
| 20 | Viridian Therapeutics Inc | 2,819,500 | 82.8M $ | 1.34 % |
| 21 | UnitedHealth Group Inc | 280,000 | 82.1M $ | 1.33 % |
| 22 | Nuvalent Inc | 760,000 | 77.5M $ | 1.25 % |
| 23 | Roche Holding AG | 160,000 | 76.1M $ | 1.23 % |
| 24 | Cencora Inc | 200,000 | 74.4M $ | 1.20 % |
| 25 | Royalty Pharma PLC | 1,500,000 | 69.3M $ | 1.12 % |
| 26 | Insulet Corp | 270,000 | 66.6M $ | 1.07 % |
| 27 | Waystar Holding Corp | 2,500,000 | 64.1M $ | 1.03 % |
| 28 | Vaxcyte Inc | 1,000,000 | 61.7M $ | 1.00 % |
| 29 | Caris Life Sciences Inc | 3,050,000 | 61.4M $ | 0.99 % |
| 30 | Stryker Corp | 150,000 | 58.1M $ | 0.94 % |
| 31 | Xenon Pharmaceuticals Inc | 1,290,000 | 55.8M $ | 0.90 % |
| 32 | Repligen Corp | 428,000 | 55.1M $ | 0.89 % |
| 33 | Veeva Systems Inc | 300,000 | 54.6M $ | 0.88 % |
| 34 | Privia Health Group Inc | 2,280,000 | 54.2M $ | 0.87 % |
| 35 | Praxis Precision Medicines Inc | 160,000 | 53.9M $ | 0.87 % |
| 36 | LEGEND BIOTECH CORP | 2,800,000 | 53.2M $ | 0.86 % |
| 37 | Crinetics Pharmaceuticals Inc | 1,280,000 | 52.6M $ | 0.85 % |
| 38 | Intuitive Surgical Inc | 100,000 | 50.4M $ | 0.81 % |
| 39 | Medline Inc | 1,000,000 | 47.5M $ | 0.77 % |
| 40 | CG oncology Inc | 800,000 | 47M $ | 0.76 % |
| 41 | CENTESSA PHARMACEUTICALS PLC | 1,650,000 | 44.3M $ | 0.72 % |
| 42 | Disc Medicine Inc | 650,000 | 43.3M $ | 0.70 % |
| 43 | Spyre Therapeutics Inc | 940,000 | 40.4M $ | 0.65 % |
| 44 | Structure Therapeutics Inc | 620,000 | 39M $ | 0.63 % |
| 45 | Alignment Healthcare Inc | 2,000,000 | 38.4M $ | 0.62 % |
| 46 | Enliven Therapeutics Inc | 1,280,000 | 38M $ | 0.61 % |
| 47 | Veracyte Inc | 1,030,144 | 37.7M $ | 0.61 % |
| 48 | Cytokinetics Inc | 600,000 | 37.3M $ | 0.60 % |
| 49 | Roivant Sciences Ltd | 1,280,000 | 37M $ | 0.60 % |
| 50 | 10X Genomics Inc | 1,600,000 | 36.9M $ | 0.60 % |
| 51 | Kiniksa Pharmaceuticals International Plc | 800,000 | 35.6M $ | 0.57 % |
| 52 | Oruka Therapeutics Inc | 1,006,510 | 34.6M $ | 0.56 % |
| 53 | Olema Pharmaceuticals Inc | 1,350,000 | 32.7M $ | 0.53 % |
| 54 | LifeStance Health Group Inc | 4,500,000 | 32.6M $ | 0.53 % |
| 55 | BioNTech SE | 280,000 | 30.9M $ | 0.50 % |
| 56 | Mineralys Therapeutics Inc | 1,000,000 | 29.3M $ | 0.47 % |
| 57 | Cigna Group/The | 100,000 | 29M $ | 0.47 % |
| 58 | BEONE MEDICINES LTD | 90,000 | 28.5M $ | 0.46 % |
| 59 | ZENAS BIOPHARMA INC | 1,080,000 | 28.5M $ | 0.46 % |
| 60 | Sartorius Stedim Biotech | 128,000 | 27.7M $ | 0.45 % |
| 61 | Stoke Therapeutics Inc | 750,000 | 27.3M $ | 0.44 % |
| 62 | Newamsterdam Pharma Co NV | 670,000 | 23.8M $ | 0.38 % |
| 63 | Pharvaris NV | 800,000 | 22.7M $ | 0.37 % |
| 64 | WaVe Life Sciences Ltd | 1,600,000 | 22.3M $ | 0.36 % |
| 65 | Kymera Therapeutics Inc | 243,586 | 22.3M $ | 0.36 % |
| 66 | HeartFlow Inc | 950,000 | 22M $ | 0.36 % |
| 67 | Amylyx Pharmaceuticals Inc | 1,420,000 | 21.5M $ | 0.35 % |
| 68 | Kestra Medical Technologies Ltd | 900,000 | 21M $ | 0.34 % |
| 69 | Viking Therapeutics Inc | 600,000 | 20.3M $ | 0.33 % |
| 70 | Axsome Therapeutics Inc | 118,000 | 19.3M $ | 0.31 % |
| 71 | CytomX Therapeutics Inc | 3,400,000 | 18.3M $ | 0.29 % |
| 72 | Guardant Health Inc | 194,000 | 18.2M $ | 0.29 % |
| 73 | Summit Therapeutics Inc | 1,000,000 | 16.6M $ | 0.27 % |
| 74 | Travere Therapeutics Inc | 550,000 | 16.4M $ | 0.26 % |
| 75 | Immunocore Holdings PLC | 500,000 | 16.2M $ | 0.26 % |
| 76 | Soleno Therapeutics Inc | 400,000 | 15.6M $ | 0.25 % |
| 77 | DAMORA THERAPEUTICS INC | 500,000 | 14.8M $ | 0.24 % |
| 78 | Trevi Therapeutics Inc | 1,000,000 | 11.9M $ | 0.19 % |
| 79 | Mirum Pharmaceuticals Inc | 128,000 | 11.8M $ | 0.19 % |
| 80 | IQVIA Holdings Inc | 60,000 | 10.7M $ | 0.17 % |
| 81 | Omada Health Inc | 850,000 | 10.4M $ | 0.17 % |
| 82 | Revolution Medicines Inc | 100,000 | 10.2M $ | 0.16 % |
| 83 | Biogen Inc | 50,000 | 9.6M $ | 0.15 % |
| 84 | MBX Biosciences Inc | 280,000 | 9.1M $ | 0.15 % |
| 85 | uniQure NV | 540,000 | 8.4M $ | 0.14 % |
| 86 | Rapport Therapeutics Inc | 285,000 | 8.3M $ | 0.13 % |
| 87 | Contineum Therapeutics Inc | 450,000 | 6.9M $ | 0.11 % |
| 88 | Annexon Inc | 1,200,000 | 6.7M $ | 0.11 % |
| 89 | Upstream Bio Inc | 800,000 | 6.1M $ | 0.10 % |
| 90 | JADE BIOSCIENCES INC | 400,000 | 5.9M $ | 0.10 % |
| 91 | Bio-Techne Corp | 100,000 | 5.9M $ | 0.10 % |
| 92 | Apogee Therapeutics Inc | 79,691 | 5.6M $ | 0.09 % |
| 93 | Outset Medical Inc | 1,520,000 | 5.3M $ | 0.09 % |
| 94 | Scholar Rock Holding Corp | 116,515 | 5.2M $ | 0.08 % |
| 95 | Ocular Therapeutix Inc | 494,535 | 4.4M $ | 0.07 % |
| 96 | Acumen Pharmaceuticals Inc | 1,140,000 | 3.6M $ | 0.06 % |
| 97 | Surgery Partners Inc | 145,113 | 2.2M $ | 0.04 % |
| 98 | Shoulder Innovations Inc | 96,700 | 1.3M $ | 0.02 % |
| 99 | SALUDA MEDICAL INC | 1,600,000 | 1.2M $ | 0.02 % |
| 100 | Immunome Inc | 46,826 | 1M $ | 0.02 % |
Sector breakdown
- Health care 59.3 %
- Technology 0.9 %
- Unattributed 39.8 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 95.6 %
- EUR 3.1 %
- CHF 1.3 %
The quoted currency of each line, as declared.
Country breakdown
- United States 85.7 %
- Netherlands 3.5 %
- Denmark 2.8 %
- Belgium 2.7 %
- Switzerland 1.3 %
- Bermuda 1.0 %
- Canada 0.9 %
- Cayman Islands 0.9 %
- Germany 0.5 %
- France 0.5 %
- Singapore 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 86 | 5.2B $ | 85.74 % |
| 2 | Netherlands | 4 | 208.3M $ | 3.45 % |
| 3 | Denmark | 1 | 167.2M $ | 2.77 % |
| 4 | Belgium | 1 | 161M $ | 2.67 % |
| 5 | Switzerland | 1 | 76.1M $ | 1.26 % |
| 6 | Bermuda | 2 | 58M $ | 0.96 % |
| 7 | Canada | 1 | 55.8M $ | 0.92 % |
| 8 | Cayman Islands | 1 | 53.2M $ | 0.88 % |
| 9 | Germany | 1 | 30.9M $ | 0.51 % |
| 10 | France | 1 | 27.7M $ | 0.46 % |
| 11 | Singapore | 1 | 22.3M $ | 0.37 % |
Cite this page
Titelia. "Holdings of Select Health Care Portfolio". https://titelia.com/en/funds/S000007466